[go: up one dir, main page]

ES2126643T3 - Sales de un acido quinoloncarboxilico. - Google Patents

Sales de un acido quinoloncarboxilico.

Info

Publication number
ES2126643T3
ES2126643T3 ES93902562T ES93902562T ES2126643T3 ES 2126643 T3 ES2126643 T3 ES 2126643T3 ES 93902562 T ES93902562 T ES 93902562T ES 93902562 T ES93902562 T ES 93902562T ES 2126643 T3 ES2126643 T3 ES 2126643T3
Authority
ES
Spain
Prior art keywords
salts
acid
quinoloncarboxilic
carboxylic acid
quinolon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902562T
Other languages
English (en)
Inventor
Kyu Jeong Yeon
Je Hak Kim
Kyung Eob Choi
Dal Hyun Kim
Ki Ho Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ Corp
Original Assignee
CJ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ Corp filed Critical CJ Corp
Application granted granted Critical
Publication of ES2126643T3 publication Critical patent/ES2126643T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTAN NUEVAS SALES DE ADICION DE ACIDOS ORGANICOS DE UN ACIDO QUINOLON-CARBOXILICO DE LA FORMULA (I) EN LA QUE Z ES ACIDO 5-OXOTETRAHIDROFURAN2-CARBOXILICO O ACIDO 2-HIDROXIGLUTARICO. LAS SALES SON MUY SOLUBLES EN AGUA Y POR TANTO SON ADECUADAS PARA LA PREPARACION DE UNA INYECCION ESTABLE QUE SE PUEDE CONSERVAR DURANTE UN LARGO PERIODO DE TIEMPO.
ES93902562T 1992-01-21 1993-01-21 Sales de un acido quinoloncarboxilico. Expired - Lifetime ES2126643T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920000794A KR0159540B1 (ko) 1992-01-21 1992-01-21 퀴놀론-카복실산의 염 및 그 함유조성물

Publications (1)

Publication Number Publication Date
ES2126643T3 true ES2126643T3 (es) 1999-04-01

Family

ID=19328138

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902562T Expired - Lifetime ES2126643T3 (es) 1992-01-21 1993-01-21 Sales de un acido quinoloncarboxilico.

Country Status (7)

Country Link
US (1) US5484785A (es)
EP (1) EP0640074B1 (es)
JP (1) JP2642245B2 (es)
KR (1) KR0159540B1 (es)
DE (1) DE69322081T2 (es)
ES (1) ES2126643T3 (es)
WO (1) WO1993014068A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN186245B (es) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
KR100840125B1 (ko) * 2001-06-28 2008-06-19 씨제이제일제당 (주) 항균화합물의 고농도 수용액 조성물
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188181B (en) * 1981-06-11 1986-03-28 Warner-Lambert Co,Us Process for producing salts of naphtiridine and quinoline compounds of antimicrobial activity
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
IT1196051B (it) * 1984-03-16 1988-11-10 Schiena Ricerche Composti ad attivita' antibatterica
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
WO1993014068A1 (en) 1993-07-22
EP0640074A1 (en) 1995-03-01
EP0640074B1 (en) 1998-11-11
DE69322081D1 (de) 1998-12-17
KR930016415A (ko) 1993-08-26
KR0159540B1 (ko) 1998-12-01
US5484785A (en) 1996-01-16
JPH07502535A (ja) 1995-03-16
JP2642245B2 (ja) 1997-08-20
DE69322081T2 (de) 1999-07-08

Similar Documents

Publication Publication Date Title
EE03999B1 (et) Fumaarhappe derivaatide kasutamine
ES2147230T3 (es) Derivados de aminoacidos, medicamentos que contienen a estos compuestos y procedimiento para su preparacion.
ES2084073T3 (es) Aclarados finales libres de cromo para metal fosfatado.
ATE90570T1 (de) Verbesserte formulierungen mit kontrollierter abgabe.
ES8800720A1 (es) Un procedimiento para la preparacion de derivados carbonilicos de peptidasas electrofilicamente activadas.
ES2120993T3 (es) Agentes antitromboticos.
ES2175244T3 (es) Empleo de acido poliasparaginico y de sus sales.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ES2075315T3 (es) Procedimiento para la preparacion de acidos (6s)- y (6r)-tetrahidrofolicos.
DE3682136D1 (de) N-substituierte 5-nitroanthranilsaeuren, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
ES2178205T3 (es) Compuestos amida indazol como agentes serotoninergicos.
ES2117426T3 (es) Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
ES2041705T3 (es) Procedimiento para la preparacion de 1-(4-hidroxi-3,5-di-terc-butil-benzoil)-homopiperazina y sus derivados.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
ES2029030T3 (es) Un procedimiento para producir una preparacion acuosa de la sal de potasio de 9-metil-3-(1h-tetrazol-5-il)-4h-pirido (1,2-a)pirimidin-4-ona.
ES2038733T3 (es) Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
ES2169223T3 (es) Substancia anticancerosa que inhibe la metastasis cancerosa.
ES2090807T3 (es) Procedimiento para la obtencion de sales hidroxilamonio o-substituidas.
ES2126643T3 (es) Sales de un acido quinoloncarboxilico.
ES2103486T3 (es) Medicamentos que contienen acidos difosfonicos y sus sales.
CO4290351A1 (es) Proceso
ES2172589T3 (es) Tratamiento de la apoplegia asociada con la infiltracion de macrofagos.
ES2163528T3 (es) Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
ES2053765T3 (es) Derivados antibacterianos de 9-desoxo-9a-alilo y propargil-9a-aza-9a-homoeritromicina a.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 640074

Country of ref document: ES